Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03281343
Other study ID # R34DA045621
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 29, 2017
Est. completion date August 31, 2023

Study information

Verified date April 2023
Source Rhode Island Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pre-exposure prophylaxis (PrEP) can be very effective at preventing HIV infection among women at high-risk for HIV but is underused in this population. Periods of incarceration represent an opportunity to identify women at risk and link them to PrEP care as they leave jail or prison. This study aims to improve linkage to community-based PrEP care to reduce HIV acquisition in a high-need, underserved community.


Description:

Incarcerated women engage in high rates of sex- and drug-related behavior that place them at risk for HIV. Pre-exposure prophylaxis (PrEP) is an efficacious means of reducing HIV acquisition. There is a general lack of knowledge regarding PrEP among women at elevated risk, and only a small percentage of at-risk women are currently engaged in PrEP care. The period of incarceration represents an opportunity to identify at-risk women, initiate PrEP during incarceration, and establish linkage to community-based PrEP care upon release from incarceration. Further, post-release is a time period that is particularly risky, and there are numerous barriers that may impede linkage to community-based care in the absence of intervention. To date, very little research has been done to improve linkage to PrEP care among US women. The proposed study will examine the acceptability, feasibility, and preliminary efficacy of a psychoeducation and motivational interviewing intervention to promote PrEP initiation during incarceration, followed by a patient navigator intervention to facilitate linkage to community-based PrEP care upon release from incarceration. The long-term goal of this line of research is to disseminate an efficacious PrEP Care linkage intervention for at-risk women post-release from incarceration. The present proposal seeks to develop intervention materials and conduct a small randomized controlled trial (RCT) of the intervention.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 80
Est. completion date August 31, 2023
Est. primary completion date October 31, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Female at birth; at least 18 years of age; not currently pregnant; risk behavior prior to incarceration that meets CDC indications for PrEP; likely to be incarcerated for less than 6 months; able to understand and speak English and to provide written and verbal informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Motivational Interviewing & Patient Navigator
The specific content, structure, and implementation approach for MI-NAV will be guided by IDIs conducted during Phase 1 and Phase 2. Our initial plan is to deliver MI-NAV in two waves. The first wave will be aimed at promoting uptake of PrEP at the prison, through the use of motivational interviewing. The second wave will be aimed at linking at-risk women to community-based PrEP care upon release from incarceration, by utilizing a patient navigator approach.
Standard of Care (SOC)
SOC will consist of a pamphlet regarding PrEP during incarceration, an offer of PrEP while incarcerated, and referral to community-based PrEP care upon release.

Locations

Country Name City State
United States Rhode Island Hospital Providence Rhode Island

Sponsors (1)

Lead Sponsor Collaborator
Rhode Island Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rates of linkage to community-based PrEP care Linkage to community-based care is operationalized as receipt of a prescription for PrEP from a community-based provider within 3 months of release from prison, confirmed through medical record data extraction. 3 Months post-release
Secondary PrEP Adherence PrEP adherence will be determined by drug concentrations in urine samples collected from participants who have been prescribed PrEP at 3 and 6 months. Presence of PrEP will be assessed with immunoassay developed by UrSure Inc. 3 Months and 6 Months post-release
Secondary PrEP Care Retention PrEP retention in care will be defined as attending 3-month clinical appointments (+/- 1 month) which is in accordance with current CDC guidelines. This will be verified with medical records. 3 Month clinical appointments (+/- 1 month)
Secondary Alcohol and Drug Use The Timeline Followback (TLFB) will be used to assess alcohol and drug use behavior at baseline, as well as during the follow-up interviews. 6-months
Secondary HIV Risk Behavior The TLFB will be used to assess drug and sex risk behavior at baseline and during the follow-up interviews. In addition, the HIV Risk Assessment Battery will serve as a measure of overall sex and drug risk behavior. 6-months
Secondary Depressive Symptoms The Center for Epidemiologic Studies Depression Scale (CES-D) will be administered at baseline and follow-up interviews to assess depressive symptoms 6-months
Secondary Treatment Received and Medications/Pregnancies The Treatment Services Review (TSR) and Use of Medications Questionnaire will be used to measure the number and types of treatment services utilized, medications prescribed, and pregnancies experienced during the follow-up period. 6-months
See also
  Status Clinical Trial Phase
Completed NCT05509049 - Precision Nudging Drives Wellness Visit Attendance at Scale N/A
Active, not recruiting NCT05667974 - A Study to Evaluate a PIKA Rabies Vaccine(Vero Cell)for Human Use,Freeze-dried Phase 3
Not yet recruiting NCT06335121 - Implementation of PrEP Care Among Women in Family Planning Clinics N/A
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Terminated NCT01395238 - Enhancing Father's Ability to Support Their Preschool Child N/A
Completed NCT00589173 - An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care N/A
Completed NCT00535665 - Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine Phase 2
Completed NCT00814554 - Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers N/A
Completed NCT00995462 - Prevention of Weight Gain in University Students N/A
Completed NCT00966212 - Parent Education for Young Teen Females Phase 2/Phase 3
Completed NCT04526873 - Encouraging Annual Wellness Visits Among ACO Beneficiaries N/A
Recruiting NCT06112249 - SAFE Workplace Intervention for People With IDD N/A
Completed NCT04977700 - Using Physical Tracking to Predict Sunburn N/A
Completed NCT04032145 - Characterization of Health Conditions of Visitors of the Montreal Museum of Fine Arts
Completed NCT04785599 - Lymphedema Prevention After Lymph Node Emptying N/A
Recruiting NCT05050266 - Enhancing Mental and Physical Health of Women Veterans N/A
Recruiting NCT01021488 - Rosuvastatin for Preventing Deep Vein Thrombosis Phase 4
Terminated NCT02247258 - Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence. Phase 2
Recruiting NCT05903885 - A Cross-sectional Partnership to Improve Prevention N/A
Completed NCT04162977 - Adapting Personality-Targeted Interventions for Reducing Substance Misuse and Related Outcomes in Youth in Youth Protection Services N/A